Cadence Pharmaceuticals Inc Asset Turnover Ratio (CADX), as of fourth quarter 2013, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cadence Pharmaceuticals Inc  (CADX)
 

Cadence Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cadence Pharmaceuticals Inc asset turnover ratio, the ability of Cadence Pharmaceuticals Inc's assets to generate revenue in the fourth quarter 2013, increased sequentially to 0.61 in the fourth quarter (Dec 31 2013), yet the ratio remained below the average, as CADX's position remain challenging.

Within sector 3 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2013 compared to the preceding quarter from 0 to 1135.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CADX Asset Turnover Ratio (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter
Y / Y Asset Change -7.04 % -65.71 % 17.76 % 83.05 % -39.35 %
Y / Y Revenue Change 105.62 % 108.35 % 122.13 % 195 % 191.63 %
Asset Turnover Ratio (TTM) 0.61 0.51 0.35 0.31 0.27
CADX's Total Ranking # 1135 # 0 # 0 # #
Seq. Asset Change 8.07 % -72.5 % 18.99 % 162.92 % -60.13 %
Seq. Revenue Change 21.95 % 17.36 % 4.5 % 37.49 % 23.57 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 78
Overall Market # 1135

Asset Turnover Ratio Statistics
High Average Low
1.25 0.65 0.21
(Dec 31 2013)   (Jun 30 2012)




CADX Company Profile • Back to CADX Efficiency Comparisons • Compare CADX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2013, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2013 Assets at quarter ending Dec 31 2013
Biolife Solutions Inc   3.32 $ 11.120  Millions$ 3.354  Millions
Aethlon Medical Inc   3.30 $ 1.321  Millions$ 0.400  Millions
Musclepharm Corporation  3.23 $ 110.878  Millions$ 34.373  Millions
Gt Biopharma Inc   3.06 $ 0.368  Millions$ 0.120  Millions
Healthcare Services Group Inc   3.04 $ 1,149.890  Millions$ 378.336  Millions
Zeo Scientifix Inc   2.74 $ 0.086  Millions$ 0.031  Millions
Reliv International Inc  2.59 $ 68.207  Millions$ 26.386  Millions
Noho, Inc.  2.45 $ 0.980  Millions$ 0.400  Millions
Pacific Health Care Organization Inc  2.33 $ 6.573  Millions$ 2.826  Millions
Bionik Laboratories Corp   2.20 $ 0.005  Millions$ 0.002  Millions
Magellan Health inc   2.18 $ 3,546.317  Millions$ 1,626.482  Millions
Interpace Biosciences Inc   2.15 $ 162.757  Millions$ 75.588  Millions
American Caresource Holdings, Inc.  2.14 $ 26.751  Millions$ 12.478  Millions
Diversicare Healthcare Services Inc   2.14 $ 281.919  Millions$ 131.687  Millions
Tenet Healthcare Corp  2.13 $ 23,176.000  Millions$ 10,884.500  Millions
Lifemd Inc   1.93 $ 0.808  Millions$ 0.418  Millions
Nature s Sunshine Products inc   1.90 $ 375.876  Millions$ 197.646  Millions
Dynatronics Corporation  1.90 $ 28.536  Millions$ 15.018  Millions
Ernexa Therapeutics Inc   1.89 $ 23.749  Millions$ 12.579  Millions
Hca Healthcare Inc   1.88 $ 53,066.000  Millions$ 28,260.000  Millions
Iqvia Holdings Inc   1.86 $ 5,099.545  Millions$ 2,745.923  Millions
Adm Tronics Unlimited Inc   1.85 $ 1.621  Millions$ 0.877  Millions
Psychemedics Corporation  1.81 $ 26.870  Millions$ 14.863  Millions
Insite Vision Inc  1.80 $ 30.822  Millions$ 17.079  Millions
Henry Schein Inc   1.80 $ 9,560.647  Millions$ 5,318.229  Millions
American Bio Medica Corporation  1.79 $ 8.894  Millions$ 4.979  Millions
Biolase Inc   1.78 $ 56.430  Millions$ 31.721  Millions
Panbela Therapeutics Inc   1.77 $ 0.974  Millions$ 0.550  Millions
Mit Holding, Inc.  1.75 $ 1.563  Millions$ 0.894  Millions
Bioxytran Inc   1.74 $ 0.417  Millions$ 0.239  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.